Global Dental Burs Market 2024
The global dental burs market is projected to expand at a CAGR of ~5.6 percent across the forecast period of 2024 – 2030, according to the latest edition of the…
$2,600.00
According to Gen Consulting Company, the global emerging medical device technologies market is set to achieve an incremental growth of USD 104 billion, acelerating at a CAGR of almost 12.3% during the forecast period 2022-2028.
The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global emerging medical device technologies market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the emerging medical device technologies industry.
This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the segment, and region. The global market for emerging medical device technologies can be segmented by segment: cardiovascular, diabetes, drug delivery, gastrointestinal endoscopy, IVD (vitro diagnostic), neurology, ophthal, orthopedic, wound care. Globally, the cardiovascular segment made up the largest share of the emerging medical device technologies market. Emerging medical device technologies market is further segmented by region: Asia Pacific, Europe, North America, Rest of the World (RoW). North America captured the largest share of the market in 2021.
By segment:
– cardiovascular
– diabetes
– drug delivery
– gastrointestinal endoscopy
– IVD (vitro diagnostic)
– neurology
– ophthal
– orthopedic
– wound care
By region:
– Asia Pacific
– Europe
– North America
– Rest of the World (RoW)
The cardiovascular devices market is further segmented into electrophysiology (EP), endovascular aortic repair (EVAR), heart failure devices, interventional cardiology (IC), peripheral vascular devices (PVD), subcutaneous ICD, transcatheter heart valve therapy. The heart failure devices segment was the largest contributor to the global emerging medical device technologies market in 2021. Furthermore, the IVD devices market has been categorized into advanced cancer molecular diagnostics, companion diagnostics, professional POC. The professional POC segment is estimated to account for the largest share of the global emerging medical device technologies market. The orthopedic devices market is further divided into extremity joint reconstruction, soft tissue fixation and repair. The soft tissue fixation and repair segment held the largest share of the global emerging medical device technologies market in 2021 and is anticipated to hold its share during the forecast period.
The report also provides a detailed analysis of several leading emerging medical device technologies market vendors that include 3M Company, Abbott Laboratories, Agilent Technologies, Inc., Allergan Inc., Biolase, Inc., BioMerieux S.A., Boston Scientific Corp., Cardinal Health, Inc., Cook Group, Cordis Corporation, Edwards Lifesciences Corporation, GE Healthcare, Illumina, Inc., Karl Storz SE & Co. KG, Medtronic plc, Mindray Medical International Limited, Myriad Genetics, Inc., Nidek Co., Ltd., Novartis International AG, Roche Holding AG, Shimadzu Corp., Siemens Healthineers, Smith & Nephew plc, Stryker Corporation, Terumo Corp., Zimmer Biomet Holdings, Inc., among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.
Scope of the Report
– To analyze and forecast the market size of the global emerging medical device technologies market.
– To classify and forecast the global emerging medical device technologies market based on segment, region.
– To identify drivers and challenges for the global emerging medical device technologies market.
– To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global emerging medical device technologies market.
– To identify and analyze the profile of leading players operating in the global emerging medical device technologies market.
Why Choose This Report
– Gain a reliable outlook of the global emerging medical device technologies market forecasts from 2022 to 2028 across scenarios.
– Identify growth segments for investment.
– Stay ahead of competitors through company profiles and market data.
– The market estimate for ease of analysis across scenarios in Excel format.
– Strategy consulting and research support for three months.
– Print authentication provided for the single-user license.
TABLE OF CONTENTS
FIGURES AND TABLES
PART 1. INTRODUCTION
· Report description
· Objectives of the study
· Market segment
· Years considered for the report
· Currency
· Key target audience
PART 2. METHODOLOGY
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
· Introduction
· Drivers
· Restraints
· Impact of COVID-19 pandemic
PART 5. MARKET BREAKDOWN BY SEGMENT
· Cardiovascular
· Diabetes
· Drug delivery
· Gastrointestinal endoscopy
· IVD (vitro diagnostic)
· Neurology
· Ophthal
· Orthopedic
· Wound care
PART 6. MARKET BREAKDOWN BY REGION
· Asia Pacific
· Europe
· North America
· Rest of the World (RoW)
PART 7. KEY COMPANIES
· 3M Company
· Abbott Laboratories
· Agilent Technologies, Inc.
· Allergan Inc.
· Biolase, Inc.
· BioMerieux S.A.
· Boston Scientific Corp.
· Cardinal Health, Inc.
· Cook Group
· Cordis Corporation
· Edwards Lifesciences Corporation
· GE Healthcare
· Illumina, Inc.
· Karl Storz SE & Co. KG
· Medtronic plc
· Mindray Medical International Limited
· Myriad Genetics, Inc.
· Nidek Co., Ltd.
· Novartis International AG
· Roche Holding AG
· Shimadzu Corp.
· Siemens Healthineers
· Smith & Nephew plc
· Stryker Corporation
· Terumo Corp.
· Zimmer Biomet Holdings, Inc.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER
3M Company
Abbott Laboratories
Agilent Technologies, Inc.
Allergan Inc.
Biolase, Inc.
BioMerieux S.A.
Boston Scientific Corp.
Cardinal Health, Inc.
Cook Group
Cordis Corporation
Edwards Lifesciences Corporation
GE Healthcare
Illumina, Inc.
Karl Storz SE & Co. KG
Medtronic plc
Mindray Medical International Limited
Myriad Genetics, Inc.
Nidek Co., Ltd.
Novartis International AG
Roche Holding AG
Shimadzu Corp.
Siemens Healthineers
Smith & Nephew plc
Stryker Corporation
Terumo Corp.
Zimmer Biomet Holdings, Inc.
REPORT ATTRIBUTE | DETAILS |
---|---|
Base Year | 2021 |
Forecast Year | 2022-2028 |
CAGR (2022-2028) | 12.3% |
Pages | 93 |
Key Players | 3M Company, Abbott Laboratories, Agilent Technologies Inc., Allergan Inc., Biolase Inc., BioMerieux S.A., Boston Scientific Corp., Cardinal Health Inc., Cook Group, Cordis Corporation, Edwards Lifesciences Corporation, GE Healthcare, Illumina Inc., Karl Storz SE & Co. KG, Medtronic plc, Mindray Medical International Limited, Myriad Genetics Inc., Nidek Co. Ltd., Novartis International AG, Roche Holding AG, Shimadzu Corp., Siemens Healthineers, Smith & Nephew plc, Stryker Corporation, Terumo Corp., Zimmer Biomet Holdings Inc. |
The global dental burs market is projected to expand at a CAGR of ~5.6 percent across the forecast period of 2024 – 2030, according to the latest edition of the…
The global urology laser market is estimated to increase at the rate of 5.6% each year in the period from 2023 to 2029. Urology lasers are medical devices specifically designed…
The global scar management market, in terms of revenue, is anticipated to progress at a CAGR of 5.8% during the forecast period, 2023-2029. Scar management encompasses various techniques and treatments…
Please fill out our form and we will get back to you.